Friday, October 8, 2021
BETWEEN A ROCK AND A HARD PLACE
Wednesday, October 6, 2021
Of one- sided ethics
https://timesofindia.indiatimes.com/city/mumbai/mumbai-pharma-co-allowed-cost-of-france-workshop-for-docs-as-tax-deduction/articleshow/86739550.cms
"Mumbai Pharma Co allowed cost of France workshop for docs as tax deduction"
further ITAT tribunal has commented that the ethical guideline issued by Medical Council of India forbidding financial arrangements with pharma companies applies SOLELY to doctors and not to Pharma companies.
Now the ball is in the regulatory body's court- should they pull up the doctor's for accepting this junket? Or stay silent so the epidemic swells....Also is there no such thing as 'abetment of malpractice' ? and no reasonable mandate for its prevention.
As one wise person said "In today's healthcare índustry' pharma, corporates and tech are the big fish. Doctors and patients are bit players. So it will be that doctors and patients interests will be compromised to uphold the so-called larger interest of industry and progress" Hence what is completely unethical for doctors and detrimental to patients is absolutely allowed and encouraged for Pharma companies- as in above example.